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The pyruvate dehydrogenase complex (PDHc) is a multiprotein
system that links glycolysis with the TCA cycle by oxidative
decarboxylation of pyruvate to acetyl-CoA. It consists of three
catalytic enzymes (El, E2 and E3), a protein with an as yet
unknown function (protein X) and two regulatory enzymes
(PDH phosphatase and PDH kinase) monitoring the activation/
inactivation of the complex by dephosphorylation/phos
phorylation of the El component (1).
PDHc deficiencies have been associated with a wide
spectrum of clinical presentations ranging from mild
intermittent ataxia to severe neonatal lactic acidosis and early
death (1-3). Although almost equal numbers of male and
female patients with a PDHc deficiency have been described,
most of the molecular defects have been localised in the X-
linked El a component of El (4).
We report on a 18-month-old dysmorphic female with a 4
base pair (bp) deletion in exon 10 of the Ela gene on one of
her X-chromosomes. She presented with a severe metabolic
acidosis: lactate and pyruvate concentrations in blood were
5.5 mM and 0.43 mM (UP ratio 13:1), respectively, and 6.7
raM and 0.80 mM in cerebrospinal fluid (UP ratio 8:1). She
had complete agenesis of the corpus callosum, cortical atrophy,
microgyria and was micro- and hydrocephalic. She developed
early onset quadriplegia and myoclonic epilepsy. PDHc activity
was measured in mononuclear cells, fibroblasts and muscle
mitochondria and was 19%, 31% and 17%, respectively, of
normal control values (5). Oxidation of pyruvate by intact
mitochondria isolated from the patient's muscle was found to
be very low (45%) compared to control values. In contrast,
glutamate and succinate were normally oxidized. All muscle
respiratory complexes, measured by spectrophotometry, were
found to be normal. Western blot analysis of the patient's
cultured fibroblasts showed normal PDH subunit
immunoreactivity (data not shown). The whole coding region
of the E l a gene was studied by SSCP analysis of six
overlapping PCR fragments (W.Lissens et al., submitted) and
showed one abnormally migrating fragment. This fragment of
248 bp, defined by primers PDS3 (AGTGGATGGAA-
TGGATATCC; cDNA nucleotide positions 864-883 (4)) and
PDS4 (TTTAGTTCTTCCACACTGGC; cDNA nucleotide
positions 1112-1093), and spanning exon 8, exon 9 and part
of exon 10, was reamplified by PCR and directly sequenced
in both directions. A mutation was localised close to primer
PDS4 in exon 10, and for confirmation, exon 10 was reamplified
from genomic muscle DNA using intron 9 primer PDH 10
(TTTCATCACGCCGTCCTTGC) and intron 10 primer PDH70
(AACTTTTAAAGCCAACCTTC). Part of the sequence of
this 226 bp fragment at the position of the mutation is shown
in Figure 1. A normal Ela sequence was found in either
direction, but starting from T at nucleotide position 1041 a
second sequence was superimposed on the normal one. Close
inspection indicated that the second sequence is an out of
phase E l a sequence lacking 4 bp from nucleotides AAGTAAG
at cDNA positions 1038-1044, resulting in AAG. Due to the
direct repeat AAG around the central T, it was not possible to
determine the exact position of the deletion since the removal
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Figure 1. Direct sequence analysis of PCR-amplified exon 10 of the E l a
gene of the patient in sense (primer PDH 10) and antisense (primer PDH70)
direction, using the Sequenase kit version 2.0 (USB). The arrows indicate the
start of the superposition of a 4 bp deleted sequence on the normal one. The
T at this position corresponds to bp 1041 in the normal E l a cDNA.
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of four consecutive bases from this sequence will always result
in AAG.
Our patient is thus a heterozygous carrier of a normal and
a 4 bp deleted El a gene. Inspection of the SSCP and cDNA
sequencing gels indicated that in muscle the two alleles are
expressed at a 35%/65% proportion (data not shown). The 4
bp deletion predicts a reading frame shift in the El a
polypeptide after amino acid 311 and a premature stop codon
at position 324. The mutation was not found in the mother's
genomic white blood cell DNA by sequencing of the PDHIO/
PDH70 PCR fragment. The father was not available for study.
In our patient, the 4 bp deletion is found in a 9 bp 2 bp
overlapping, direct repeat sequence (QAAGTAAG.AAGTA-
AGA; underline: start of each 9 bp repeat; the T in bold
corresponds to nucleotide position 1041), in which four AAG
repeats are present. In a study by Krawczak and Cooper (6)
of small gene deletions in human genetic disease, direct repeats
are a common feature of all but one of 60 deletions analysed.
Their results also indicate that small deletions are more
compatible with a model of mutagenesis based on slipping
mispairing during replication than with recombination or repair
of DNA. The 4 bp deletion in our patient could easily be
explained by the modified slipped mispairing hypothesis they
propose: during replication, slipping mispairing of the fourth
AAG repeat with the second one on the complementary strand,
with looping out and excision of the AAGT sequence in
between, would result in two daughter duplexes, one of which
lacks the third AAG repeat and the T between repeats 3 and
4. Two alternative slipped mispairing structures could also
explain the excision of 4 bp from the AAGTAAG sequence,
but would be less stable than the former one since homology
of only two bases (looping of AGTA) or one base (looping of
GTAA) would be involved in loop formation. The fourth
possibility, deletion of TAAG, could not be explained by this
hypothesis. We therefore propose to refer to the mutation in
our patient as 1038del4 (7). It is also noteworthy to mention
that the 9 bp repeat sequence contains, albeit in opposite
orientation, a 6 bp sequence (AGAAGT; cDNA nucleotide
positions 1036-1041) that perfectly matches with a consensus
sequence recognised as a hotspot for deletion (6). So far, three
other females have been described with small deletions in the
9 bp repeat (8-10) and all of these, including our patient, have
a 'cerebral' form of PDH deficiency (11,12).
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